hydromorphone has been researched along with Chronic Disease in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (10.00) | 18.2507 |
| 2000's | 26 (65.00) | 29.6817 |
| 2010's | 10 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quigley, C | 2 |
| Turris, M | 1 |
| Greenfield, S; Jamison, RN; Janfaza, D; Michna, E; Teter, CJ; Wasan, AD | 1 |
| Baccelieri, A; Bijur, PE; Chang, AK; Gallagher, EJ | 1 |
| Firnhaber-Burgos, JB; Grewal, PK | 1 |
| Gröning, R; Richarz, U; Sathyan, G; Thipphawong, J; Turgeon, J | 1 |
| Carter, NJ; Keating, GM | 1 |
| Hale, M; Khan, A; Kutch, M; Li, S | 1 |
| Gould, EM; Peniston, JH; Xiang, Q | 1 |
| Jacobs, A; Moulin, DE; Richarz, U; Thipphawong, J; Wallace, M | 1 |
| Dusci, LJ; Fairclough, D; Goucke, CR; Ilett, KF; Van Leeuwen, S | 1 |
| Coluzzi, F; Mattia, C | 1 |
| Hale, ME; Kutch, M; Nalamachu, SR | 1 |
| Bansal, M; Happich, M; Klein, R; Wielage, R; Wilson, K | 1 |
| Quigley, C; Wiffen, P | 1 |
| Ackerman, LL; Follett, KA; Rosenquist, RW | 1 |
| Dunn, E; McCartney, C; Peng, P; Rudich, Z | 1 |
| Sittig, HB | 1 |
| Ashby, M; Good, P; Goodchild, C; Jackson, K; Tullio, F | 1 |
| Häring, HU; Knaus-Dittmann, D; Mörike, K; Müssig, K; Schmidt, H | 1 |
| Khanna, S; Skowronski, R; Thipphawong, J; Tudor, IC; Wallace, M | 1 |
| Bozkaya, D; Caro, JJ; Dubois, D; Fleischmann, J; Sabatowski, R; Ward, A | 1 |
| Hale, M; Khanna, S; Thipphawong, J; Tudor, IC | 1 |
| Khanna, S; Moulin, D; Rauck, RL; Thipphawong, J; Tudor, IC; Wallace, M | 1 |
| Friedrichsdorf, SJ; Kang, TI | 1 |
| Giesecke, T; Sabatowski, R | 1 |
| Couch, JP; Liu, HN; Ruan, X; Shah, R; Wang, F | 1 |
| Eipe, N; Kay, J | 1 |
| Güttler, K; Sabatowski, R | 1 |
| Babul, N; Darke, AC; Dhaliwal, H; Hagen, N; Harsanyi, Z; Hays, H; Thirlwell, M | 1 |
| MacConnachie, AM | 1 |
| Angst, MS; Brose, WG; Dyck, JB | 1 |
| Derby, SA | 1 |
| Midroni, G; Moulton, R | 1 |
| McCaffery, M; Pasero, C | 1 |
| Deer, TR; Elsberry, DD; Hildebrand, KR | 1 |
| Kefalianakis, F; Kugler, G; Kugler, M; van der Auwera, R | 1 |
| Brookoff, D; Damask, MC; Dornseif, BE; Doyle, RT; Northfelt, DW; Palangio, M; Portenoy, RK | 1 |
12 review(s) available for hydromorphone and Chronic Disease
| Article | Year |
|---|---|
WITHDRAWN: Hydromorphone for acute and chronic pain.
Topics: Acute Disease; Analgesics, Opioid; Chronic Disease; Humans; Hydromorphone; Pain; Randomized Controlled Trials as Topic | 2013 |
The pharmacokinetics of a long-acting OROS hydromorphone formulation.
Topics: Administration, Oral; Chronic Disease; Delayed-Action Preparations; Humans; Hydromorphone; Pain | 2010 |
OROS hydromorphone prolonged release: a review of its use in the management of chronic, moderate to severe pain.
Topics: Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Drug Interactions; Humans; Hydromorphone; Molecular Structure; Pain; Severity of Illness Index; Treatment Outcome | 2010 |
Efficacy of the sustained-release hydromorphone in neuropathic pain management: pooled analysis of three open-label studies.
Topics: Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydromorphone; Male; Middle Aged; Neuralgia; Pain Measurement; Palliative Care; Treatment Outcome | 2010 |
OROS® hydromorphone in chronic pain management: when drug delivery technology matches clinical needs.
Topics: Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Delivery Systems; Humans; Hydromorphone; Osmotic Pressure; Pain; Randomized Controlled Trials as Topic | 2010 |
Safety and Tolerability of Once-Daily OROS(®) hydromorphone extended-release in opioid-tolerant adults with moderate-to-severe chronic cancer and noncancer pain: pooled analysis of 11 clinical studies.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Chronic Pain; Clinical Trials as Topic; Comorbidity; Evidence-Based Medicine; Female; Humans; Hydromorphone; Incidence; Male; Middle Aged; Neoplasms; Opioid-Related Disorders; Risk Assessment; Risk Factors; Severity of Illness Index; Sex Distribution; United States; Young Adult | 2012 |
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes | 2013 |
A systematic review of hydromorphone in acute and chronic pain.
Topics: Acute Disease; Analgesics, Opioid; Chronic Disease; Humans; Hydromorphone; Pain; Palliative Care | 2003 |
The management of pain in children with life-limiting illnesses.
Topics: Analgesics, Opioid; Child; Chronic Disease; Codeine; Fentanyl; Humans; Hydromorphone; Ketamine; Methadone; Morphine; Nociceptors; Oxycodone; Pain; Pain Measurement; Severity of Illness Index | 2007 |
[Pharmacotherapy of chronic, non-tumour related pain. Efficacy, tolerability and patient benefit of an oral osmotic system with hydromorphone].
Topics: Activities of Daily Living; Administration, Oral; Analgesics, Opioid; Arthritis; Back Pain; Chronic Disease; Delayed-Action Preparations; Humans; Hydromorphone; Longitudinal Studies; Multicenter Studies as Topic; Osmosis; Pain; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Sleep; Surveys and Questionnaires; Time Factors; Treatment Outcome; World Health Organization | 2007 |
[Differential therapeutic aspects of analgesia with oral sustained-release strong opioids: application intervals, metabolism and immunosuppression].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Evidence-Based Medicine; Female; Humans; Hydromorphone; Immunity, Cellular; Male; Metabolic Clearance Rate; Middle Aged; Morphine; Oxycodone; Pain; Randomized Controlled Trials as Topic | 2008 |
Hydromorphone for acute and chronic pain.
Topics: Acute Disease; Analgesics, Opioid; Chronic Disease; Humans; Hydromorphone; Pain; Randomized Controlled Trials as Topic | 2002 |
11 trial(s) available for hydromorphone and Chronic Disease
| Article | Year |
|---|---|
Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in chronic pain patients treated with morphine.
Topics: Chronic Disease; Female; Humans; Hydromorphone; Male; Middle Aged; Morphine; Pain; Prevalence; Reproducibility of Results; Sensitivity and Specificity; Substance Abuse Detection; Urinalysis | 2008 |
Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Emergency Service, Hospital; Female; Humans; Hydromorphone; Male; Morphine; Pain; Pain Measurement; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2009 |
Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Drug Tolerance; Female; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Placebos; Quebec; Treatment Outcome; Young Adult | 2010 |
Stability and tolerability of high concentrations of intrathecal bupivacaine and opioid mixtures in chronic noncancer pain: an open-label pilot study.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Chromatography, High Pressure Liquid; Chronic Disease; Drug Stability; Female; Humans; Hydromorphone; Infusion Pumps, Implantable; Injections, Spinal; Male; Middle Aged; Morphine; Pain; Pain Measurement; Pilot Projects | 2010 |
Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Chronic Disease; Clonidine; Drug Therapy, Combination; Female; Humans; Hydromorphone; Infusion Pumps, Implantable; Injections, Spinal; Male; Middle Aged; Pain; Treatment Outcome | 2003 |
Stability of clonidine in clonidine-hydromorphone mixture from implanted intrathecal infusion pumps in chronic pain patients.
Topics: Analgesics; Chronic Disease; Clonidine; Complex Mixtures; Drug Combinations; Drug Stability; Drug Storage; Humans; Hydromorphone; Infusion Pumps, Implantable; Injections, Spinal; Pain; Quality Assurance, Health Care | 2004 |
Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127).
Topics: Administration, Oral; Adult; Algorithms; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Pain Measurement; Pilot Projects; Quality of Life; Sleep; Treatment Outcome | 2007 |
Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Female; Hip; Humans; Hydromorphone; Knee; Male; Middle Aged; Osteoarthritis; Oxycodone; Pain | 2007 |
Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study.
Topics: Adult; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Delivery Systems; Female; Humans; Hydromorphone; Male; Middle Aged; Pain; Pain Measurement; Patient Satisfaction; Surveys and Questionnaires; Titrimetry; Treatment Outcome | 2007 |
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain.
Topics: Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Pain Measurement | 1994 |
Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain.
Topics: Adult; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Delivery Systems; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Titrimetry | 2002 |
17 other study(ies) available for hydromorphone and Chronic Disease
| Article | Year |
|---|---|
The use of topical opioids for systemic pain management.
Topics: Administration, Topical; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Dose-Response Relationship, Drug; Drug Compounding; Humans; Hydromorphone; Male; Pain | 2008 |
The epidural works, but the patient hurts! Acute pain management of the chronic pain patient.
Topics: Acute Disease; Analgesia, Epidural; Analgesics, Opioid; Chronic Disease; Continuity of Patient Care; Drug Therapy, Combination; Fentanyl; Humans; Hydromorphone; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Opioid-Related Disorders; Pain, Postoperative; Practice Guidelines as Topic; Substance Withdrawal Syndrome | 2009 |
Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain - an individual patient analysis.
Topics: Aged; Analgesics, Opioid; Chronic Disease; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Oxycodone; Oxymorphone; Pain Measurement; Patient Acceptance of Health Care; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
[Pain reduced and quality of life improved by sustained-release hydromorphone. Results of an observational study].
Topics: Aged; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Hydromorphone; Middle Aged; Pain; Pain Measurement; Quality of Life | 2004 |
Prospective audit of short-term concurrent ketamine, opioid and anti-inflammatory ('triple-agent') therapy for episodes of acute on chronic pain.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dexamethasone; Drug Therapy, Combination; Humans; Hydromorphone; Ketamine; Ketorolac; Male; Middle Aged; Oxycodone; Pain; Prospective Studies | 2005 |
Palladone for chronic pain.
Topics: Biological Availability; Chronic Disease; Delayed-Action Preparations; Humans; Hydromorphone; Pain; Substance-Related Disorders | 2005 |
Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment.
Topics: Adrenal Insufficiency; Adult; Amenorrhea; Analgesics, Opioid; Chronic Disease; Female; Humans; Hydromorphone; Pain | 2007 |
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
Topics: Analgesics, Opioid; Chronic Disease; Cohort Studies; Cost-Benefit Analysis; Delayed-Action Preparations; Germany; Humans; Hydromorphone; Osteoarthritis; Oxycodone; Pain; Sleep; Treatment Outcome | 2007 |
Persistent hiccup associated with intrathecal morphine infusion pump therapy.
Topics: Aged; Analgesics, Opioid; Chronic Disease; Female; Hiccup; Humans; Hydromorphone; Infusion Pumps; Injections, Spinal; Lumbar Vertebrae; Morphine; Risk Factors; Time Factors | 2007 |
Spontaneously breathing technique for opioid tolerance.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthetics, Inhalation; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Drug Tolerance; Fentanyl; Fractures, Bone; Humans; Humerus; Hydromorphone; Intubation, Intratracheal; Ketorolac; Male; Marijuana Abuse; Methyl Ethers; Opioid-Related Disorders; Orthopedic Procedures; Pain; Respiration; Sevoflurane | 2008 |
Analgesics in the management of chronic pain. Part four: Step 3 oral analgesic drug therapy.
Topics: Administration, Oral; Analgesics, Opioid; Chronic Disease; Dextromoramide; Drug Administration Schedule; Humans; Hydromorphone; Morphine; Pain | 1998 |
The relationship between the visual analog pain intensity and pain relief scale changes during analgesic drug studies in chronic pain patients.
Topics: Adult; Aged; Analgesics, Opioid; Chronic Disease; Female; Humans; Hydromorphone; Male; Methadone; Middle Aged; Pain; Pain Measurement; Regression Analysis | 1999 |
Opioid conversion guidelines for managing adult cancer pain.
Topics: Administration, Oral; Analgesics, Opioid; Chronic Disease; Female; Humans; Hydromorphone; Infusions, Intravenous; Mathematics; Middle Aged; Morphine; Neoplasms; Pain; Pain Measurement; Salvage Therapy; Therapeutic Equivalency; Titrimetry | 1999 |
Radial entrapment neuropathy due to chronic injection-induced triceps fibrosis.
Topics: Adult; Chronic Disease; Diazepam; Dimenhydrinate; Diphenhydramine; Drug Therapy, Combination; Electrodiagnosis; Female; Fibrosis; Humans; Hydromorphone; Injections, Intramuscular; Male; Meperidine; Middle Aged; Muscle, Skeletal; Nerve Compression Syndromes; Neural Conduction; Radial Neuropathy; Reaction Time; Somatoform Disorders | 2001 |
Hydromorphone.
Topics: Analgesics, Opioid; Chronic Disease; Humans; Hydromorphone; Meperidine; Morphine; Neoplasms; Pain | 2001 |
Stability, compatibility, and safety of intrathecal bupivacaine administered chronically via an implantable delivery system.
Topics: Analgesics, Opioid; Anesthesia, Spinal; Anesthetics, Local; Bupivacaine; Chronic Disease; Drug Delivery Systems; Drug Stability; Drug Therapy, Combination; Humans; Hydromorphone; Morphine; Pain; Pain Measurement; Palliative Care; Retrospective Studies; Safety | 2001 |
[Opioid rotation in pain therapy. Case report].
Topics: Administration, Cutaneous; Chronic Disease; Fentanyl; Humans; Hydromorphone; Injections, Subcutaneous; Male; Middle Aged; Morphine; Neoplasms; Pain | 2002 |